Neurodegenrative changes in retina of rats with chronic epileptic syndrome under conditions of treatment with niacin-oxy-ethylidene-phosphonate germanate (MIGU-4)
DOI:
https://doi.org/10.31288/oftalmolzh202322630Keywords:
pentylenetetrazol kindling, chronic epileptic syndrome, retinopathy, niacin-oxy-ethylidene-phosphonate germinate (MIGU-4), neuroprotectionAbstract
Background: Epilepsy is accompanied by neurodegenerative changes, particularly those in the retina. Elucidation of the mechanisms of retinal alterations in a model of epileptic syndrome may allow for the development of new approaches to pharmacological vision correction.
Purpose: To assess the morphological characteristics of the retina, particularly treated with niacin oxy-ethylidene phosphonate germinate (MIGU-4), in the pentylenetetrazole (PTZ)-induced kindling model of chronic epileptic syndrome.
Material and Methods: PTZ was administered in Wistar male rats intraperitoneally (i.p.) at a daily dose of 35.0 mg/kg for 21 days. Rats with fully-developed generalized seizures were treated with MIGU-4 ip at a daily dose of 5.0 mg/kg or 25.0 mg/kg for 28 days. Thereafter, the animals were euthanized, their globes were enucleated, and retinal sections were prepared and stained with hematoxylin and eosin for morphological examination.
Results: Cell density in the retinal ganglion cell layer was 2.14 times lower, and in the inner nuclear layer and outer nuclear layer, 41.0% and 19.0%, respectively, lower for the rats with fully developed kindled seizures than for controls (р < 0.05). In the presence of treatment with MIGU-4 ip at a daily dose of 25.0 mg/kg, cell density in the retinal ganglion cell layer and in the inner nuclear layer was 38% and 30.5%, respectively, higher than for controls (р < 0.05). There was no significant difference in the cell density in the outer nuclear layer between rats treated with MIGU-4 ip at a daily dose of 5 mg/kg or 25.0 mg/kg and controls (р > 0.05).
Conclusion: The PTZ-induced kindling model of chronic epileptic syndrome is accompanied by degenerative changes in the eye. A course of treatment with MIGU-4 causes neuroptotective effects in a model of PTZ-induced retinopathy.
References
Волошенков ДБ, Кащенко ОА, Годован ВВ, Шандра ОА. Вплив похідних дифосфонату германію з нікотинамідом, нікотиновою кислотою та магнієм на ригидність м'язів, тремор і салівацію у щурів та мишей. Одеський мед. журнал. 2005;4 (90):21-4.
Годован ВВ, Кресюн ВЙ. Стан системи антиоксидантного захисту клітини при галактозаміновому гепатиті та застосуванні похідних оксіетилідендифосфонатогерманатів (Повідомлення 1). Одеський мед. журнал. 2007а;4 (102):36-41.
Годован ВВ, Кресюн ВЙ. Стан системи антиоксидантного захисту клітини при галактозаміновому гепатиті та застосуванні похідних оксіетилідендифосфонатогерманатів (Повідомлення 2). Одеський мед. журнал. 2007б;5(103):С. 5-10.
Кресюн НВ. Нейродегенеративні зміни сітківки ока щурів зі стрептозотоциновим діабетом за різних умов експериментального лікування. Запорізький мед. журнал. 2014;4:21-5.
Wada Т, Hanyu Т, Nozaki K, et al. Antioxidant activity of Ge-132, a synthetic organic germanium, on cultured mammalian cells. Biol. Pharm. Bull. 2018;41(5)749-53. https://doi.org/10.1248/bpb.b17-00949
Devinsky О, Vezzani А, O'Brienetal Т. Epilepsy. NatRevDisPrimers. 2018;4. AreticleID 18024. https://doi.org/10.1038/nrdp.2018.24
Cho JM, Chae J, Jeong SR, et al. Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights. PLoS One. 2020;15(10). Article ID e0240358. https://doi.org/10.1371/journal.pone.0240358
Ahl M, Avdic U, Skoug C, et al. Immune response in the eye following epileptic seizures. Neuroinflamm. 2016;13:155. https://doi.org/10.1186/s12974-016-0618-3
Jaiswal G, Kumar P. Neuroprotective role of apocynin against pentylenetetrazole kindling epilepsy and associated comorbidities in mice by suppression of ROS/RNS. Behav. Brain Res. 2022;419. https://doi.org/10.1016/j.bbr.2021.113699
Kresyun NV, Godlevskii LS. Superoxide dismutase and catalase activities in the retina during experimental diabetes and electric stimulation of the paleocerebellar cortex. Bull. Exp. Biol. Med. 2014;158(2):206-8. https://doi.org/10.1007/s10517-014-2723-6
Bayraktar BN, Titiz AP, Bilen S, et al. Optical coherence tomography and neurodegeneration in epilepsy. Eur. J. Ophthalmol. 2021;31(1);252-7. https://doi.org/10.1177/1120672119881982
Takeda T, Doiyama S, Azumiet J, et al. Organogermanium suppresses cell death due to oxidative stress in normal human dermal fibroblasts. Sci Rep. 2019;9. Article ID 13637. https://doi.org/10.1038/s41598-019-49883-7
El-Megiri N, Mostafa YM, Ahmed А, et al. Pioglitazone ameliorates hippocampal neurodegeneration, disturbances in glucose metabolism and AKT/mTOR signaling pathways in pentyelenetetrazole-kindled mice. Pharmaceuticals. 2022;5:1113. https://doi.org/10.3390/ph15091113
Hazirolan D, Duman M, Guler SK, et al. Retinal ganglion cell complex and visual evoked potentials in levetiracetam treatment. Cutan. Ocul. Toxicol. 2020;39(3);237-43. https://doi.org/10.1080/15569527.2020.1778016
Shandra AA, Godlevsky LS. Antiepileptic effects of cerebellar nucleus dentatus electrical stimulation under different conditions of brain epileptisation. Indian J Exp Biol. 1990;28(2):158-61.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Нора Джавад Аль-Надаві , Валентин Кресюн
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.